Frontpage | European Medicines Agency

17/10/2018

Shaping regulatory science to 2025

EMA is hosting a workshop on Wednesday, 24 October to gather insight from stakeholders on the key areas in human medicines to be covered in its ‘Regulatory Science Strategy to 2025’, a proposed new high-level plan for advancing its engagement with...

15/10/2018

Sales of antibiotics for use in food-producing animals drop across the EU

A report published today by the European Medicines Agency (EMA) shows that the overall sales of veterinary antimicrobials across Europe have decreased by more than 20% between 2011 and 2016. This continues the downward trend seen over the last few...

15/10/2018

EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU

EU authorities are placing the Chinese company Zheijiang Huahai under increased supervision following European and US inspections which revealed weaknesses in quality management at the company’s Chuannan site in Linhai, China. The inspection...

12/10/2018

Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 October 2018

CVMP initiates two referral procedures to harmonise consumer safety aspects of veterinary medicines containing paromomycin and tylosin, respectively

09/10/2018

Update on EMA’s Brexit preparedness

The European Medicines Agency’s (EMA) Brexit preparedness business continuity plan (BCP) entered into its third phase on 1 October 2018, as announced at the beginning of August 2018 . The temporary suspension or reduction of additional activities in...

05/10/2018

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 October 2018

At its monthly meeting, the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded a referral and confirmed its advice in the context of a safety signal evaluation. More information on all safety referrals...

Select your language

Shaping regulatory science to 2025

Shaping regulatory science to 2025

Sales of antibiotics for use in animals drop across the EU

Sales of antibiotics for use in animals drop across the EU

Update on Brexit preparations

Update on Brexit preparations

Boosting the development of medicines for children

Boosting the development of medicines for children

Shaping regulatory science to 2025

Sales of antibiotics for use in food-producing animals drop across the EU

EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU

Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 October 2018

Update on EMA’s Brexit preparedness

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 October 2018

Information for

Key content

Product emergency hotline

UK’s withdrawal from the EU

PRIME: Priority medicines

Pharmacovigilance (safety monitoring)

Data on medicines

Clinical data publication

Careers

Services & databases

Account Management portal

eSubmission

EudraVigilance (human)

EU Veterinary Medicinal Product Database

Suspected adverse drug reactions database

Clinical data

SPOR data management services

How does EMA work?

What we do

Our role in authorisation of medicines

Who we are

Our scientific experts

How we work

What we publish

Shaping regulatory science to 2025

Shaping regulatory science to 2025

Sales of antibiotics for use in animals drop across the EU

Sales of antibiotics for use in animals drop across the EU

Update on Brexit preparations

Update on Brexit preparations

Boosting the development of medicines for children

Boosting the development of medicines for children

Latest news

Shaping regulatory science to 2025

Sales of antibiotics for use in food-producing animals drop across the EU

EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU

Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 October 2018

Update on EMA’s Brexit preparedness

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 October 2018

Information for

Key content

Product emergency hotline

UK’s withdrawal from the EU

PRIME: Priority medicines

Pharmacovigilance (safety monitoring)

Data on medicines

Clinical data publication

Careers

Services & databases

Account Management portal

eSubmission

EudraVigilance (human)

EU Veterinary Medicinal Product Database

Suspected adverse drug reactions database

Clinical data

SPOR data management services

How does EMA work?

What we do

Our role in authorisation of medicines

Who we are

Our scientific experts

How we work

What we publish